Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Express Scripts Holding Co    ESRX

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Express Scripts Earnings Surged 74%; Forecast Clears Lowered Hurdle

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/18/2013 | 11:18pm CEST
   By Jon Kamp 
 

Pharmacy-benefit manager Express Scripts Holding Co. (>> Express Scripts Holding Co) reported a 74% surge in fourth-quarter earnings, helped by a major acquisition, while forecasting 2013 earnings mostly ahead of a Wall Street target the company helped drag lower three months ago.

The St. Louis-based company--which manages drug-benefit programs for health plans and corporate customers--rattled analysts in November when it said their forecasts for 2013 looked too high. Express Scripts didn't release its own guidance at the time, but said a still-weak economy was weighing on the number of prescriptions it handles.

Monday's release finally included company guidance for adjusted earnings of $4.20 to $4.30 per share this year. The target is largely above the $4.20 forecast among analysts surveyed by Thomson Reuters, although Express Scripts' November warning caused analysts to trim the consensus forecast by about 30 cents since then.

This will mark the first full year of combined operations for Express Scripts and Medco Health Solutions, which created the largest pharmacy-benefit manager, or PBM, following April's $29.1 billion Medco acquisition.

"2012 was a monumental year for Express Scripts as we closed the acquisition of Medco and made significant progress integrating the two companies," George Paz, Express Scripts' chief executive, said in a press release.

The company plans to hold a conference call Tuesday morning. Its shares are up about 2.9% so far this year, through Friday's close, trailing a 6.6% gain in the Standard & Poor's 500 index.

The company reported fourth-quarter earnings of $504.1 million, or 61 cents a share, up from $290.4 million, or 59 cents a share, a year earlier. Excluding deal-related costs and other items, per-share earnings rose to $1.05 from 82 cents.

Revenue more than doubled to $27.41 billion from the year-earlier period, which was before the Medco deal.

Analysts surveyed by Thomson Reuters had forecast earnings of $1.04 a share on sales of $27.24 billion. Analysts are forecasting lower sales in coming quarters as health insurer UnitedHealth Group Inc. (>> UnitedHealth Group Inc.) brings in-house the PBM business it had outsourced to Medco.

Express Scripts saw adjusted claims--a measure that takes into account monthly prescriptions filled in retail pharmacies and 90-day fills through the company's mail-order business--rise 111% in the recent quarter to 410.8 million.

The company's full-year adjusted claims tally about matched its target by nearing 1.4 billion. The company expects 5% to 7% growth in adjusted claims this year.

Its adjusted earnings forecast represents 12% to 15% growth.

Write to Jon Kamp at [email protected]

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Stocks mentioned in the article : Express Scripts Holding Co, UnitedHealth Group Inc.
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on EXPRESS SCRIPTS HOLDING CO
09/15 EXPRESS SCRIPTS : Mallinckrodt Pharmaceuticals - Open Letter to Mallinckrodt Emp..
09/14 EXPRESS SCRIPTS : Missouri lawmakers urge governor to rein in budget changes
09/07 EXPRESS SCRIPTS : Offers Important Prescription Drug Information for Residents I..
09/05 Express Scripts Holding Company Announces Third Quarter 2017 Earnings Confere..
08/31 EXPRESS SCRIPTS : Research Shows Significant Benefit of Adherence to Diabetes Me..
08/30 EXPRESS SCRIPTS : to Present at an Upcoming Conference
08/28 INSIDER TRADING ACTIVITY EXPRESS SCR : ESRX) – VP Sold 1,163 shares of Sto..
08/26 Health plans report progress in limiting opioid use
08/25 EXPRESS SCRIPTS : Research Shows Significant Benefit of Adherence to Diabetes Me..
08/23 EXPRESS SCRIPTS : Consent for automatic prescription refills begins Sept. 1
More news
News from SeekingAlpha
09/19 Ray Dalio's Principles & Top 7 Most Undervalued Stocks
09/19 Premarket analyst action - healthcare new coverage
09/12 Express Scripts slips on Chanos' continued bearish thesis
09/08 Mallinckrodt Is A Short As Employees Now Join Express Scripts As Critics
08/25 Synergy's Festering Issue
Financials ($)
Sales 2017 101 B
EBIT 2017 6 811 M
Net income 2017 3 117 M
Debt 2017 11 459 M
Yield 2017 -
P/E ratio 2017 11,39
P/E ratio 2018 10,34
EV / Sales 2017 0,46x
EV / Sales 2018 0,44x
Capitalization 35 230 M
Chart EXPRESS SCRIPTS HOLDING CO
Duration : Period :
Express Scripts Holding Co Technical Analysis Chart | ESRX | US30219G1085 | 4-Traders
Technical analysis trends EXPRESS SCRIPTS HOLDING CO
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 21
Average target price 67,3 $
Spread / Average Target 10%
EPS Revisions
Managers
NameTitle
Timothy C. Wentworth President, Chief Executive Officer & Director
George Paz Chairman
Christine Houston Chief Operating Officer & Executive Vice President
Eric R. Slusser Chief Financial Officer & Executive Vice President
Steven B. Miller Chief Medical Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
EXPRESS SCRIPTS HOLDING CO-8.93%35 230
WALGREENS BOOTS ALLIANCE-0.31%86 903
CVS HEALTH5.58%84 477
MCKESSON CORPORATION6.71%31 196
CARDINAL HEALTH INC-6.21%20 968
AMERISOURCEBERGEN CORP.4.36%17 371